Profitelligence Profitelligence · Filing Ledger Search all insiders →

Insider Profile · SEC Form 4 Activity · Trailing 90 Days

Thompson Peter A.

Over the trailing 90 days, Thompson Peter A. (Director at Sionna Therapeutics, Inc.) sold $22.5M of stock across 4 companies, per 10 SEC Form 4 transactions.

Role
Director
Companies
SION SPRY CRVS EWTX
Window
Trailing 90 days · 10 transactions · CIK 1357522
Net activity
−$22.5M ($0 bought · $22.5M sold)

By Company (Trailing 90 Days)

SymbolCompanyTxnsBoughtSoldNet
SIONSionna Therapeutics, Inc.7$22.5M−$22.5M
SPRYARS Pharmaceuticals, Inc.1$0
CRVSCorvus Pharmaceuticals, Inc.1$0
EWTXEdgewise Therapeutics, Inc.1$0

Transactions (10)

DateSymbolTypeSharesValueDescription
2026-07-07SIONSell85.9K$3.9MOpen market or private sale
2026-06-30SIONSell115.8K$5.3MOpen market or private sale
2026-06-24SPRYBuy30.0K$0Grant, award or other acquisition
2026-06-17SIONBuy17.3K$0Grant, award or other acquisition
2026-06-11CRVSBuy15.0K$0Grant, award or other acquisition
2026-06-05EWTXBuy16.4K$0Grant, award or other acquisition
2026-05-27SIONSell101$4KOpen market or private sale
2026-05-11SIONSell184.6K$8.5MOpen market or private sale
2026-05-08SIONSell59.8K$2.7MOpen market or private sale
2026-05-07SIONSell48.5K$2.2MOpen market or private sale

Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.

Follow Thompson's next move

Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.

Start free